VICTORIA WONG: Open Payments
NPI 1437693918 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$18,660 in 82 payments from 12 companies in 2025. Trend: 2023 $16,981 · 2024 $3,983 · 2025 $18,660
Speaker / faculty: $13,106Consulting: $3,030Food & beverage: $1,798Travel & lodging: $725
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 44 | $17,663 |
| AstraZeneca Pharmaceuticals LP | 7 | $192 |
| Exelixis Inc. | 4 | $190 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $156 |
| Merck Sharp & Dohme LLC | 5 | $112 |
| Daiichi Sankyo Inc. | 4 | $100 |
| PFIZER INC. | 4 | $87 |
| Novartis Pharmaceuticals Corporation | 3 | $47 |
| Astellas Pharma US Inc | 2 | $46 |
| Gilead Sciences, Inc. | 1 | $28 |
Products named: RYBREVANT, ERLEADA, CABOMETYX, Nubeqa, Enhertu, KEYTRUDA, Padcev, Xtandi.
Industry payments across PA — which companies pay providers there.
